Drug Profile
JTT 553
Latest Information Update: 12 Sep 2008
Price :
$50
*
At a glance
- Originator Japan Tobacco
- Class
- Mechanism of Action Diacylglycerol O acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 30 Jun 2008 Discontinued - Phase-I for Obesity (PO)
- 09 Aug 2007 Phase-I clinical trials in Obesity (PO)